In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma
Ontology highlight
ABSTRACT: In vivo screen identifies LXR agonism potentiates sorafenib killing of hepatocellular carcinoma
PROVIDER: PRJNA635711 | ENA |
REPOSITORIES: ENA
ACCESS DATA